The CRISPR/Cas system protects bacteria against bacteriophage and plasmids through a sophisticated mechanism where cas operon plays a crucial role consisting of cse1 and cas3. However, comprehensive studies on the regulation of cas3 operon of the Type I-E CRISPR/Cas system are scarce. Herein, we investigated the regulation of cas3 in Escherichia coli. The mutation in gcvP or crp reduced the CRISPR/Cas system interference ability and increased bacterial susceptibility to phage, when the casA operon of the CRISPR/Cas system was activated. The silence of the glycine cleavage system (GCS) encoded by gcvTHP operon reduced cas3 expression. Adding N5, N10-methylene tetrahydrofolate (N5, N10-mTHF), which is the product of GCS-catalyzed glycine, was able to activate cas3 expression. In addition, a cAMP receptor protein (CRP) encoded by crp activated cas3 expression via binding to the cas3 promoter in response to cAMP concentration. Since N5, N10-mTHF provides one-carbon unit for purine, we assumed GCS regulates cas3 through associating with CRP. It was evident that the mutation of gcvP failed to further reduce the cas3 expression with the crp deletion. These results illustrated a novel regulatory pathway which GCS and CRP co-regulate cas3 of the CRISPR/Cas system and contribute to the defence against invasive genetic elements, where CRP is indispensable for GCS regulation of cas3 expression.
The emergence of drug-resistant bacterial infections has profoundly impacted global public health. Key pathogens include multidrug-resistant Pseudomonas aeruginosa (MDR-PA), MDR Acinetobacter baumannii , and methicillin-resistant Staphylococcus aureus . Among these pathogens, MDR-PA carries numerous virulence factors that induce extensive tissue destruction. Its inherent ability to form biofilms promotes chronic infection persistence and multidrug resistance, leading to mortality rates up to 40%. Currently, antibiotics remain the mainstay for the treatment of MDR-PA infections. Nevertheless, the escalating prevalence of drug resistance has rendered conventional antibiotic regimens increasingly recalcitrant. Consequently, the imperative for innovative antimicrobial therapeutic modalities to combat Pseudomonas aeruginosa has intensified in the realm of public health. In this context, phage therapy, with its precise bactericidal activity and high host biosafety, has emerged as a compelling alternative. This review provides a comprehensive synthesis of recent advancements in phage therapy targeting MDR-PA, covering clinical applications, current therapeutic approaches, and emerging technological platforms. It further dissects the resistance mechanisms encountered during treatment and puts forward novel counterstrategies to address antimicrobial resistance challenges—including optimized phage-antibiotic synergy, phage genome engineering, and dynamic adaptive therapeutic frameworks—aimed at advancing clinical translation.
Introduction: Portulaca oleracea L. (purslane) is a highly nutritious and edible wild vegetable beneficial to human health. However, its impacts on the structure of gut microbiota and fecal metabolites in aging individuals remain unclear. This study aims to clarify its potential mechanisms in aging-related gut health.Methods: Naturally aged rats (18 months) were divided into two groups. One group was fed a maintenance chow, and the other was fed a mixture with 3.5% purslane for 15 weeks. Hematoxylin-eosin staining, gas chromatography-mass spectrometry, and 16S rDNA high-throughput sequencing were employed to explore the effects of purslane on the intestinal health of these rats.Results: The fecal concentrations of acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, and total short-chain fatty acids (SCFAs) were significantly increased in aging rats fed the purslane supplement. Purslane significantly reduced the relative abundance levels of Firmicutes and Fusobacteria, as well as the ratio of Firmicutes to Bacteroidetes. KEGG pathway analysis annotated 109 differential metabolites, which mainly affected metabolic pathways such as linoleic acid metabolism, arachidonic acid metabolism, primary bile acid biosynthesis, steroid biosynthesis, and steroid hormone biosynthesis. There was a strong correlation between Paracbacteroides, the Prevotella NK3B31_group, the Rikenella_RC9_gut_group, and SCFA levels. Aging rats consuming purslane had a more complete and healthy gut morphology than the control group.Discussion: These results suggested that the maintenance of intestinal health by purslane in aging rats might be associated with the targeted regulation of gut microbiota and fecal metabolites.
Escherichia coli is a Gram-negative bacterium commonly found as a commensal in the intestines of humans and other warm-blooded animals. However, certain strains are pathogenic and can cause severe ...